DexCom Inc - Company Profile

Powered by

All the data and insights you need on DexCom Inc in one report.

  • Save hours of research time and resources with
    our up-to-date DexCom Inc Strategy Report

  • Understand DexCom Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Dexcom Inc (Dexcom) designs, develops and commercializes continuous glucose monitoring (CGM) systems use by people with diabetes and healthcare providers in the hospital. The company’s major products include integrated Dexcom G6 CGM system, Dexcom Share remote monitoring system, Dexcom Real-Time API, Dexcom ONE CGM system, associated software and mobile apps. It provides Dexcom Care training to users of CGM system and other support services. The company offers products to endocrinologists, physicians, diabetes educators and others. It distributes products directly in the US, Austria, Canada, Germany, Switzerland and the UK, and also through a network of distributors in Australia, the US, New Zealand, and other countries in Asia, Europe, Africa, Latin America, and the Middle East. Dexcom is headquartered in San Diego, California, the US.

Gain a 360-degree view of DexCom Inc and make more informed decisions for your business Gain a 360-degree view of DexCom Inc and make more informed decisions for your business Find out more
Headquarters United States of America

Address 6340 Sequence Dr, San Diego, California, 92121-4356


Telephone 1 858 2000200

No of Employees 9,600

Industry Medical Equipment

Ticker Symbol & Exchange DXCM (NASD)

Revenue (2022) $3.6B 24.5% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ 58.7% (2022 vs 2021)

Market Cap* $52.5B

Net Profit Margin (2022) XYZ 27.5% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

DexCom Inc premium industry data and analytics

220+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

17+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on DexCom Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
DexCom G6 CGM System - -
Dexcom G7 Support DexCom G6
DexCom Share System Training DexCom Share
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand DexCom Inc portfolio and identify potential areas for collaboration Understand DexCom Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Contracts/Agreements In April, the company and MD Revolution entered into a partnership to combine their continuous glucose monitoring systems with MD Revolution’s remote care management platform.
2024 Regulatory Approval In March, the company secured approval from the FDA for the Stelo by Dexcom.
2024 New Products/Services In February, the company launched the new continuous glucose monitoring (CGM) system, Dexcom ONE+.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters DexCom Inc Becton Dickinson and Co Roche Diagnostics International Ltd Abbott Diabetes Care Inc Ascensia Diabetes Care US Inc
Headquarters United States of America United States of America Switzerland United States of America United States of America
City San Diego Franklin Lakes Rotkreuz Indianapolis Parsippany
State/Province California New Jersey Zug Indiana New Jersey
No. of Employees 9,600 73,000 2,600 - -
Entity Type Public Public Private Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Kevin R. Sayer Chief Executive Officer; President; Chairman Executive Board 2018 65
Jereme M. Sylvain Chief Financial Officer; Executive Vice President Senior Management 2021 43
Jacob S. Leach Chief Operating Officer; Executive Vice President Senior Management 2022 45
Shelly R. Selvaraj Senior Vice President; Chief Information Officer Senior Management 2021 64
Girish Naganathan Executive Vice President; Chief Technology Officer Senior Management 2022 46
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into DexCom Inc key executives to enhance your sales strategy Gain insight into DexCom Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward